FDA OKs implant for enlarged prostate symptoms

(AP)—Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.

The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back that presses against the urethra, causing difficulty urinating.

More than half of men in their sixties have some due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.

Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Listening to the urinary stream

Apr 23, 2008

Benign prostate enlargement affects most of the elder men and often compresses the urethra resulting in voiding symptoms. Dutch researcher Tim Idzenga has found a way to measure the resistance of the urethra using sound: ...

Recommended for you

Putting the brakes on cancer

Dec 19, 2014

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

Peanut component linked to cancer spread

Dec 19, 2014

Scientists at the University of Liverpool have found that a component of peanuts could encourage the spread and survival of cancer cells in the body.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.